Product Program year 2025 Source: CMS Open Payments

Farapulse

Device Farapulse_Ep

Open in the dashboard

General payments

$4,377,397

12,971 payments

Research payments

$960,000

6 payments

Through program year 2025, $4,377,397 in general payments and $960,000 in research payments were reported against Farapulse (Farapulse_Ep).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $4,377,397 12,971
2025 Research $710,000 5
2024 Research $250,000 1

Breakdown

Who paid General payments · program year 2025
  1. Boston Scientific Corporation $4,377,397 12,971 payments
Top recipients General payments · program year 2025
  1. Cleveland Clinic Hospital Teaching hospital · OH $1,871,790 43% · 8 payments
  2. Shephal Doshi Clinical Cardiac Electrophysiology · Santa Monica, CA $110,667 3% · 108 payments
  3. Anish Amin Clinical Cardiac Electrophysiology · Columbus, OH $84,638 2% · 86 payments
  4. Muhie Dean Sabayon Clinical Cardiac Electrophysiology · Galveston, TX $71,418 2% · 149 payments
  5. Wilber Su Cardiovascular Disease · Stanford, CA $66,209 2% · 46 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Clinical Cardiac Electrophysiology Internal Medicine $1,775,275 77% · 1,363 practitioners
  2. Cardiovascular Disease Internal Medicine $274,223 12% · 481 practitioners
  3. Internal Medicine $91,047 4% · 170 practitioners
  4. Interventional Cardiology Internal Medicine $22,125 <1% · 265 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $21,397 <1% · 226 practitioners

The top 5 of 110 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Ohio $2,105,509 48% · 121 recipients
  2. California $441,750 10% · 384 recipients
  3. Texas $260,374 6% · 320 recipients
  4. New York $218,674 5% · 291 recipients
  5. Pennsylvania $151,444 3% · 428 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

12,971 general · 6 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record